MENU
MENU
In 1995, a group of infectious disease, oncology, and hematology specialists came together to establish a scientific platform initially known as the Febrile Neutropenia Study Group. This initiative evolved into the Febrile Neutropenia Society in 2006, which has since served as a vital platform for scientists and practicing physicians dedicated to education and research in the field of immunocompromised hosts in Türkiye. Over the past 30 years, the Society has organized a biennial Febrile Neutropenia Symposium, with Postgraduate Courses held in the intervening years. Additionally, the Society has supported multicenter research projects, fostered collaborations with international organizations, and provided grants to young scientists and physicians for training abroad and conducting research.
This year, we are delighted to announce the 15th Febrile Neutropenia Symposium, which will be held online on March 15–16, 2025, in collaboration with three prominent international organizations: the International Immunocompromised Host Society (ICHS), the European Conference on Infections in Leukemia (ECIL), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). The Symposium is also endorsed by the Turkish Society of Hematology.
As you may recall, the ECIL 10 Guidelines were prepared in September 2024 and were open for public comment until recently. A series of publications related to these new guidelines are expected to be released soon. This year’s Symposium will focus on reviewing this unpublished, cutting-edge information, with presentations by experts directly involved in the development of the guidelines. Additionally, a distinguished group of international speakers will deliver lectures on the latest advancements in the management of immunocompromised hosts.
A highlight of this year’s program is the inclusion of a critical and timely topic: Ethics in Clinical Trials and Febrile Neutropenia. In collaboration with the ESCMID Ethics Advisory Committee (EEAC), experts will address ethical issues and challenges encountered in clinical trials involving this patient population.
The Symposium will also feature three dedicated sessions for young scientists and physicians. During these sessions, residents and fellows will have the opportunity to present their completed or recently published research, discuss their findings with experts, and receive valuable feedback.
The attached program outlines the comprehensive agenda for the Symposium, which will provide updates on infections in immunocompromised hosts. The event will also foster meaningful discussions, networking opportunities, and knowledge exchange among peers and renowned experts in the field.
We cordially invite you to join us for this two-day scientific event, which promises to be both informative and inspiring.
Sincerely,
On behalf of the Turkish Febrile Neutropenia Society
Murat Akova, MD
President, Turkish Febrile Neutropenia Society
Mandatory and functional cookies are used on this website, due to their necessity for our website to function properly, to navigate its content and to benefit from its features. You can disable these cookies at any time in your browser settings.Disabling cookies may cause all or some of our website's features to become unavailable. For more information about how we use cookies, you can visit our Cookie Policy. Do you accept the processing of your data via marketing cookies ?
Accept All Cookies